戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1       Alternative splicing is emerging as an oncogenic mechanism.
2 s and support condensate dysregulation as an oncogenic mechanism.
3 hogenesis and highlight a new miRNA-mediated oncogenic mechanism.
4 antiviral vaccines, and by identifying their oncogenic mechanism.
5 eloma cell lines, regardless of transforming oncogenic mechanism.
6 an thyroid cells, consistent with a dominant oncogenic mechanism.
7 s of heterozygosity remained the predominant oncogenic mechanism.
8 ion on certain Ser/Thr-Pro motifs is a major oncogenic mechanism.
9 recruit CBP/p300 as an important step of its oncogenic mechanism.
10 endent pathways which also contribute to the oncogenic mechanism.
11 vival than CM, is needed to delineate non-UV oncogenic mechanisms.
12 mutant cancers as well as insight into their oncogenic mechanisms.
13 ficantly contributed to our understanding of oncogenic mechanisms.
14 limiting investigations of enhancer-mediated oncogenic mechanisms.
15 ther these subtypes use similar or divergent oncogenic mechanisms.
16 luster into subgroups suggestive of distinct oncogenic mechanisms.
17 nitiation is a key determinant of subsequent oncogenic mechanisms.
18 is study also indicates that one model of an oncogenic mechanism, activation of a proto-oncogene by t
19  investigation, to understand the underlying oncogenic mechanism and allow the discovery of new clini
20             Our data identify PHF10 as a pro-oncogenic mechanism and an essential novel link between
21  that have shaped our understanding of MCPyV oncogenic mechanism and host cellular tropism, as well a
22  provide novel insights in understanding the oncogenic mechanism and improving the efficacy of DNA da
23                   Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN
24                          However, the direct oncogenic mechanisms and downstream effector pathways im
25            Our quantitative model can inform oncogenic mechanisms and guide development of epigenetic
26  the N-terminal fusion partner regulates the oncogenic mechanisms and output of certain RTK fusion on
27      Identifying methylated genes elucidates oncogenic mechanisms and provides valuable biomarkers; t
28            Here we identify TBC1D15-mediated oncogenic mechanisms and tested the tumorigenic roles of
29 been associated with poor prognosis, but the oncogenic mechanisms and therapeutic implications of CBL
30 cell models are a powerful tool to elucidate oncogenic mechanisms and to identify promising therapeut
31  of tyrosine kinases represents an important oncogenic mechanism, and yet the majority of such events
32 g in differentiation stage (cell of origin), oncogenic mechanisms, and clinical outcome.
33                             Potential TBC1D3 oncogenic mechanisms are discussed in light of these res
34 rare hematological disorder whose underlying oncogenic mechanisms are poorly understood.
35  topic can lead to a better understanding of oncogenic mechanisms, as well as the discovery of novel
36  ectopic expression of WNT target genes - an oncogenic mechanism associated with mutations in Adenoma
37 irst step in the biochemical analysis of the oncogenic mechanism associated with translocation (6;9),
38 view recent progress in our understanding of oncogenic mechanisms at each level of chromatin organiza
39 developments call for a re-evaluation of the oncogenic mechanisms behind PI3K pathway alterations.
40 th genomics can identify clinical strata and oncogenic mechanisms, but have been underpowered to exam
41  of DLX5 can facilitate our understanding of oncogenic mechanisms driven by overexpression of DLX5.
42 ity at tumor-suppressor loci is an important oncogenic mechanism first discovered in retinoblastomas.
43 rant Notch signaling represents an important oncogenic mechanism for T cell acute lymphoblastic leuke
44 , which will facilitate investigation of the oncogenic mechanisms for this DNA virus.
45                    The identification of key oncogenic mechanisms has brought, in recent years, a sig
46             Our studies thus uncover a novel oncogenic mechanism in Ewing sarcoma, involving post-tra
47 sine kinases (RTK) are a clinically relevant oncogenic mechanism in human cancers.
48 n of de novo DNA methylation may be a common oncogenic mechanism in leukemogenesis.
49 by polysomy 8 might represent an alternative oncogenic mechanism in lipoblastoma.
50 tural alterations emerge as a relevant early oncogenic mechanism in MCL, targeting key driver genes.
51 nal activation, which underlies the BRD4-NUT oncogenic mechanism in NMC.
52                                          The oncogenic mechanism in these fusion genes is akin to CDH
53 , since PIK3CA amplification is an important oncogenic mechanism in thyroid cancer, particularly FTC.
54  in bone, and our findings implicate a novel oncogenic mechanism in which deregulated USP6 transcript
55                  Our findings reveal a novel oncogenic mechanism in which the chromosome 19 transloca
56 ear to be alternative and mutually exclusive oncogenic mechanisms in GISTs.
57 has greatly accelerated our understanding of oncogenic mechanisms in lymphomagenesis.
58  and pathway analysis demonstrates different oncogenic mechanisms in these samples.
59                    We now report a recurrent oncogenic mechanism, in IMTs, in which tropomyosin (TPM)
60 ERK and downstream signaling, which promotes oncogenic mechanisms, including cell proliferation.
61 ibition to other tumor types driven by other oncogenic mechanisms is established.
62   Thus, Ack1 activated by surface signals or oncogenic mechanisms may directly enhance AR transcripti
63         Gaining further insights into PIK3CA oncogenic mechanisms may produce new biomarkers and help
64 ing heterogeneity, shedding light on a novel oncogenic mechanism mediated by this mutation.
65        Collectively, our results describe an oncogenic mechanism of action for ACVR1 mutations, and s
66 driver for CRPC remains controversial as the oncogenic mechanism of AR-V7 activation remains elusive.
67 ant implications on the understanding of the oncogenic mechanism of CRD-BP as well as in the future d
68 between wound healing and cancer and for the oncogenic mechanism of cyclin D.
69                         Here, we explore the oncogenic mechanism of E3-inactive CBL mutants identifie
70                     Our work clarifies a new oncogenic mechanism of EZH2 by which it interacts with H
71 ic and transcriptomic research to unveil the oncogenic mechanism of EZH2.
72 ction pioneering activity contributes to the oncogenic mechanism of FOXL2C134W and creates a potentia
73 mote apoptosis in H1299 cells, suggesting an oncogenic mechanism of GAB1.
74 lation of p100 processing may be part of the oncogenic mechanism of HTLV-I.
75 pendent of tumor proliferation rate, but the oncogenic mechanism of LMW-E and its unique function(s)
76                     To decipher the presumed oncogenic mechanism of miR-125b, we used transplantation
77 inoma may have implications for studying the oncogenic mechanism of other BRD4-associated tumors.
78  muscle cells in medullomyoblastomas and the oncogenic mechanism of OTX2 as a repressor of diverse di
79                                 Although the oncogenic mechanism of TBC1D3 has yet to be elucidated,
80  cyclin A2 by RARalpha-PLZF may represent an oncogenic mechanism of this chimeric protein and contrib
81 These findings provide key insights into the oncogenic mechanism of ZR and the importance of IDR acqu
82                                          The oncogenic mechanisms of action of ACVR1 mutations are cu
83 rely on arguably incomplete knowledge of the oncogenic mechanisms of cyclin D1.
84  vivo and in vitro results demonstrating the oncogenic mechanisms of HCV in CCA development and progr
85                                 However, the oncogenic mechanisms of most histone mutations are unkno
86 ned from these studies may shed light on the oncogenic mechanisms of other herpesviruses.
87                                          The oncogenic mechanisms of overnutrition, a confirmed indep
88  as their human counterparts with respect to oncogenic mechanisms of plasma cell transformation.
89 roviding a solid basis for investigating the oncogenic mechanisms of RNA editing and expediting the i
90                                 However, the oncogenic mechanisms of Srx in cancer are incompletely u
91 reening (HTHCS), we interrogated a number of oncogenic mechanisms of TFE3-SF fusions.
92 rogeneous properties and apparently distinct oncogenic mechanisms of these tumors.
93  there are important differences between the oncogenic mechanisms of these two viruses.
94                           To investigate the oncogenic mechanisms of this fusion gene, we developed a
95                                 However, the oncogenic mechanisms of YAP activity are unclear.
96 carcinogenesis through induction of multiple oncogenic mechanisms, perhaps contributing to the poor p
97                 To gain greater insight into oncogenic mechanisms regulated by TFAP2C, we examined ma
98              However, the cell-of-origin and oncogenic mechanism remain poorly understood.
99        However, the MCPyV life cycle and its oncogenic mechanism remain poorly understood.
100 ions at tyrosine 641 (Y641) whose underlying oncogenic mechanisms remain largely unknown.
101 ed in 10 to 40% of prostate cancers, yet its oncogenic mechanisms remain uncharacterized in vivo.
102 human hepatocellular carcinoma (HCC) but its oncogenic mechanisms remain unknown.
103                      However, the underlying oncogenic mechanisms remain unknown.
104 matological cancers; however, the underlying oncogenic mechanism remains elusive.
105  mutations in histone H3, yet the underlying oncogenic mechanism remains poorly characterized.
106 eview provides an in-depth discussion of the oncogenic mechanisms reported to be associated with dere
107 f Spry2 and c-Met signaling may be a pivotal oncogenic mechanism responsible for unrestrained activat
108              We describe a constitutive Akt1 oncogenic mechanism resulting from interaction of overex
109           These findings indicate that other oncogenic mechanism(s) may be involved in the developmen
110                     However, the synergistic oncogenic mechanisms that induce and maintain tumor cell
111 ng a wealth of testable hypotheses regarding oncogenic mechanisms that may influence the response to
112 that integration may represent an additional oncogenic mechanism through direct effects on cancer-rel
113 ring development, providing insight into the oncogenic mechanisms through which NF1 loss contributes
114 eir downstream signaling pathways is a major oncogenic mechanism underlying hematopoietic malignancie
115                Our studies shed light on the oncogenic mechanism underlying t(15;19) and provide furt
116                To investigate the underlying oncogenic mechanisms, we have cross bred transgenic stra
117                   Several new and unexpected oncogenic mechanisms were suggested by the pattern of so
118 ese data imply that CoAA may share a similar oncogenic mechanism with oncogene EWS and that CoAA dere

 
Page Top